Utility of nuclear matrix protein (NMP22) in the detection of recurrent bladder cancer
Related Experiment Video
Updated: Oct 17, 2026
05:19
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
1Department of Urology, Harvard Medical School, Boston, Massachusetts, USA.
The Urologic Clinics of North America
|March 4, 2000
Abstract:
This article examines the Nuclear Matrix Protein (NMP22) urine test for recurrent bladder cancer detection. Studies with NMP22 are compared to cytology for sensitivity and specificity. False positives and false negatives do occur, and consequences of these are discussed. Speculations are made regarding possible future uses of this test.
